Evidence map›Paper›PMID 40225389›Full record

ArticleKidney international reports2025

Recurrence of Phospholipase A2 Receptor-Associated Membranous Nephropathy in the Absence of Serum Anti-Phospholipase A2 Receptor Antibodies Reappearance.

Ilias Bensouna, Marion Delafosse, Claire Cartery, Thomas Stehlé, Clementine Rabate, Fanny Boullenger, David Buob, Jean-Jacques Boffa, Karine Dahan, Emmanuel Esteve

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Kidney international reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ilias BensounaNephrology and Dialysis Department, Hôpital Tenon, Assistance Publique-Hôpitaux de Paris, Paris, France.
Marion DelafosseNephrology and Dialysis Department, Hôpital Tenon, Assistance Publique-Hôpitaux de Paris, Paris, France.
Claire CarteryNephrology Department, Centre hospitalier de Valenciennes, Valenciennes, France.
Thomas StehléService de Néphrologie et Transplantation, Hôpitaux Universitaires Henri Mondor, Fédération Hospitalo-Universitaire (Innovative Therapy for Immune Disorders), Assistance Publique des Hôpitaux de Paris, Créteil, France.
Clementine RabateDivision of Nephrology and Dialysis, Hôpital privé Claude Galien, Ramsay Santé, Quincy-Sous-Sénart, France.
Fanny BoullengerNephrology Department, Centre hospitalier intercommunal André Grégoire, Montreuil, France.
David BuobPathology Department, Hôpital Tenon, Assistance Publique-Hôpitaux de Paris, Paris, France.
Jean-Jacques BoffaNephrology and Dialysis Department, Hôpital Tenon, Assistance Publique-Hôpitaux de Paris, Paris, France.
Karine DahanNephrology and Dialysis Department, Hôpital Tenon, Assistance Publique-Hôpitaux de Paris, Paris, France.
Emmanuel EsteveNephrology and Dialysis Department, Hôpital Tenon, Assistance Publique-Hôpitaux de Paris, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

anti-PLA2R antibodyidiopathic membranous nephropathyrelapseseronegative

Identifiers

PMID40225389
PMCPMC11993193

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.